HEADER HYDROLASE 28-MAR-11 3RAR TITLE X-RAY STRUCTURE OF A BOUND PHOSPHONATE TRANSITION STATE ANALOG AND TITLE 2 ENANTIOSELECTIVITY OF CANDIDA RUGOSA LIPASE TOWARD CHIRAL CARBOXYLIC TITLE 3 ACIDS CAVEAT 3RAR NAG B 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIPASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 16-549; COMPND 5 EC: 3.1.1.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA RUGOSA; SOURCE 3 ORGANISM_COMMON: YEAST; SOURCE 4 ORGANISM_TAXID: 5481; SOURCE 5 GENE: LIP1; SOURCE 6 EXPRESSION_SYSTEM: CANDIDA RUGOSA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: YEAST; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 5481 KEYWDS ALPHA/BETA HYDROLASE FOLD, HYDROLASE, CALCIUM BINDING, (RC, RP)- KEYWDS 2 METHYL[1-(METHOXY)PHENYLMETHYL]PHOSPHONYL ADDUCT AT OG OF SERINE 209 EXPDTA X-RAY DIFFRACTION AUTHOR P.GROCHULSKI,R.KAZLAUSKAS REVDAT 6 13-SEP-23 3RAR 1 HETSYN REVDAT 5 29-JUL-20 3RAR 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 08-NOV-17 3RAR 1 REMARK REVDAT 3 07-MAR-12 3RAR 1 JRNL SOURCE REVDAT 2 08-FEB-12 3RAR 1 SOURCE VERSN REVDAT 1 27-APR-11 3RAR 0 JRNL AUTH I.J.COLTON,D.T.YIN,P.GROCHULSKI,R.J.KAZLAUSKAS JRNL TITL INSIGHTS INTO THE MOLECULAR BASIS OF CHIRAL ACID RECOGNITION JRNL TITL 2 BY CANDIDA RUGOSA LIPASE FROM AN X-RAY CRYSTAL STRUCTURE OF JRNL TITL 3 A BOUND PHOSPHONATE TRANSITION STATE ANALOG JRNL REF ADV.SYNTH.CATAL. V. 353 2529 2011 JRNL REFN ISSN 1615-4150 JRNL DOI 10.1002/ADSC.201100459 REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 564032.690 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.9 REMARK 3 NUMBER OF REFLECTIONS : 23670 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2334 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.33 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2716 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 297 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4022 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 57 REMARK 3 SOLVENT ATOMS : 174 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.62000 REMARK 3 B22 (A**2) : -0.80000 REMARK 3 B33 (A**2) : 1.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.160 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.810 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.880 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.630 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 76.86 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : IAN.PAR REMARK 3 PARAMETER FILE 7 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 6 : IAN.TOP REMARK 3 TOPOLOGY FILE 7 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3RAR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000064700. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-95; NULL REMARK 200 TEMPERATURE (KELVIN) : 298; NULL REMARK 200 PH : 5.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N; NULL REMARK 200 RADIATION SOURCE : ROTATING ANODE; NULL REMARK 200 BEAMLINE : NULL; NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU; OTHER REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418; NULL REMARK 200 MONOCHROMATOR : GRAPHITE; NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE; NULL REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : RAXIS REMARK 200 DATA SCALING SOFTWARE : RAXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23670 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 54.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 58.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.23500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1LPP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40% (V/V) 2-METHYL-2,4-PENTANEDIOL, 30 REMARK 280 MM SODIUM ACETATE BUFFER AND 30 MM CACL2., PH 5.3, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.05000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.05000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.50000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 48.75000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.50000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 48.75000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 88.05000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.50000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 48.75000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 88.05000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.50000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 48.75000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 130.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -88.05000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 18 -61.94 74.28 REMARK 500 PRO A 32 50.46 -69.69 REMARK 500 PHE A 38 -4.65 62.44 REMARK 500 THR A 68 156.90 179.34 REMARK 500 PHE A 125 19.66 59.45 REMARK 500 SER A 159 -154.00 66.06 REMARK 500 SER A 209 -116.90 55.70 REMARK 500 SER A 241 75.18 66.04 REMARK 500 ALA A 243 -121.76 -116.37 REMARK 500 SER A 301 -121.97 43.24 REMARK 500 VAL A 313 -59.36 -125.47 REMARK 500 ASP A 317 -178.53 -171.41 REMARK 500 ASP A 340 69.50 -112.57 REMARK 500 ASP A 384 106.47 -29.74 REMARK 500 PHE A 415 -71.91 -138.71 REMARK 500 VAL A 444 -46.00 67.96 REMARK 500 ASN A 468 -80.60 -117.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 589 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 260 OD1 REMARK 620 2 ASP A 260 OD2 45.4 REMARK 620 3 HOH A 682 O 82.2 101.4 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 590 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLY A 326 O REMARK 620 2 HOH A 538 O 128.2 REMARK 620 N 1 DBREF 3RAR A 1 534 UNP P20261 LIP1_CANRU 16 549 SEQRES 1 A 534 ALA PRO THR ALA THR LEU ALA ASN GLY ASP THR ILE THR SEQRES 2 A 534 GLY LEU ASN ALA ILE ILE ASN GLU ALA PHE LEU GLY ILE SEQRES 3 A 534 PRO PHE ALA GLU PRO PRO VAL GLY ASN LEU ARG PHE LYS SEQRES 4 A 534 ASP PRO VAL PRO TYR SER GLY SER LEU ASP GLY GLN LYS SEQRES 5 A 534 PHE THR SER TYR GLY PRO SER CYS MET GLN GLN ASN PRO SEQRES 6 A 534 GLU GLY THR TYR GLU GLU ASN LEU PRO LYS ALA ALA LEU SEQRES 7 A 534 ASP LEU VAL MET GLN SER LYS VAL PHE GLU ALA VAL SER SEQRES 8 A 534 PRO SER SER GLU ASP CYS LEU THR ILE ASN VAL VAL ARG SEQRES 9 A 534 PRO PRO GLY THR LYS ALA GLY ALA ASN LEU PRO VAL MET SEQRES 10 A 534 LEU TRP ILE PHE GLY GLY GLY PHE GLU VAL GLY GLY THR SEQRES 11 A 534 SER THR PHE PRO PRO ALA GLN MET ILE THR LYS SER ILE SEQRES 12 A 534 ALA MET GLY LYS PRO ILE ILE HIS VAL SER VAL ASN TYR SEQRES 13 A 534 ARG VAL SER SER TRP GLY PHE LEU ALA GLY ASP GLU ILE SEQRES 14 A 534 LYS ALA GLU GLY SER ALA ASN ALA GLY LEU LYS ASP GLN SEQRES 15 A 534 ARG LEU GLY MET GLN TRP VAL ALA ASP ASN ILE ALA ALA SEQRES 16 A 534 PHE GLY GLY ASP PRO THR LYS VAL THR ILE PHE GLY GLU SEQRES 17 A 534 SER ALA GLY SER MET SER VAL MET CYS HIS ILE LEU TRP SEQRES 18 A 534 ASN ASP GLY ASP ASN THR TYR LYS GLY LYS PRO LEU PHE SEQRES 19 A 534 ARG ALA GLY ILE MET GLN SER GLY ALA MET VAL PRO SER SEQRES 20 A 534 ASP ALA VAL ASP GLY ILE TYR GLY ASN GLU ILE PHE ASP SEQRES 21 A 534 LEU LEU ALA SER ASN ALA GLY CYS GLY SER ALA SER ASP SEQRES 22 A 534 LYS LEU ALA CYS LEU ARG GLY VAL SER SER ASP THR LEU SEQRES 23 A 534 GLU ASP ALA THR ASN ASN THR PRO GLY PHE LEU ALA TYR SEQRES 24 A 534 SER SER LEU ARG LEU SER TYR LEU PRO ARG PRO ASP GLY SEQRES 25 A 534 VAL ASN ILE THR ASP ASP MET TYR ALA LEU VAL ARG GLU SEQRES 26 A 534 GLY LYS TYR ALA ASN ILE PRO VAL ILE ILE GLY ASP GLN SEQRES 27 A 534 ASN ASP GLU GLY THR PHE PHE GLY THR SER SER LEU ASN SEQRES 28 A 534 VAL THR THR ASP ALA GLN ALA ARG GLU TYR PHE LYS GLN SEQRES 29 A 534 SER PHE VAL HIS ALA SER ASP ALA GLU ILE ASP THR LEU SEQRES 30 A 534 MET THR ALA TYR PRO GLY ASP ILE THR GLN GLY SER PRO SEQRES 31 A 534 PHE ASP THR GLY ILE LEU ASN ALA LEU THR PRO GLN PHE SEQRES 32 A 534 LYS ARG ILE SER ALA VAL LEU GLY ASP LEU GLY PHE THR SEQRES 33 A 534 LEU ALA ARG ARG TYR PHE LEU ASN HIS TYR THR GLY GLY SEQRES 34 A 534 THR LYS TYR SER PHE LEU SER LYS GLN LEU SER GLY LEU SEQRES 35 A 534 PRO VAL LEU GLY THR PHE HIS SER ASN ASP ILE VAL PHE SEQRES 36 A 534 GLN ASP TYR LEU LEU GLY SER GLY SER LEU ILE TYR ASN SEQRES 37 A 534 ASN ALA PHE ILE ALA PHE ALA THR ASP LEU ASP PRO ASN SEQRES 38 A 534 THR ALA GLY LEU LEU VAL LYS TRP PRO GLU TYR THR SER SEQRES 39 A 534 SER SER GLN SER GLY ASN ASN LEU MET MET ILE ASN ALA SEQRES 40 A 534 LEU GLY LEU TYR THR GLY LYS ASP ASN PHE ARG THR ALA SEQRES 41 A 534 GLY TYR ASP ALA LEU PHE SER ASN PRO PRO SER PHE PHE SEQRES 42 A 534 VAL MODRES 3RAR ASN A 351 ASN GLYCOSYLATION SITE MODRES 3RAR ASN A 314 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG A 991 14 HET CA A 589 1 HET CA A 590 1 HET IAN A 560 13 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM IAN METHYL HYDROGEN (R)-[(R)-METHOXY(PHENYL) HETNAM 2 IAN METHYL]PHOSPHONATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 4 CA 2(CA 2+) FORMUL 6 IAN C9 H13 O4 P FORMUL 7 HOH *174(H2 O) HELIX 1 1 VAL A 33 ARG A 37 5 5 HELIX 2 2 ASN A 72 GLN A 83 1 12 HELIX 3 3 SER A 84 SER A 91 1 8 HELIX 4 4 GLY A 129 PHE A 133 5 5 HELIX 5 5 PRO A 135 MET A 145 1 11 HELIX 6 6 SER A 159 LEU A 164 1 6 HELIX 7 7 GLY A 166 GLY A 173 1 8 HELIX 8 8 ASN A 176 ILE A 193 1 18 HELIX 9 9 ALA A 194 PHE A 196 5 3 HELIX 10 10 SER A 209 TRP A 221 1 13 HELIX 11 11 ASN A 222 ASP A 225 5 4 HELIX 12 12 GLY A 252 ALA A 266 1 15 HELIX 13 13 ASP A 273 ARG A 279 1 7 HELIX 14 14 SER A 282 ASN A 291 1 10 HELIX 15 15 ASP A 318 GLU A 325 1 8 HELIX 16 16 GLY A 342 THR A 347 1 6 HELIX 17 17 SER A 348 LEU A 350 5 3 HELIX 18 18 THR A 354 PHE A 366 1 13 HELIX 19 19 SER A 370 TYR A 381 1 12 HELIX 20 20 ASP A 384 GLY A 388 5 5 HELIX 21 21 GLN A 402 PHE A 415 1 14 HELIX 22 22 PHE A 415 ASN A 424 1 10 HELIX 23 23 SER A 450 TYR A 458 1 9 HELIX 24 24 GLY A 463 ASN A 468 1 6 HELIX 25 25 ASN A 468 LEU A 478 1 11 HELIX 26 26 ASP A 479 GLY A 484 5 6 HELIX 27 27 ARG A 518 SER A 527 1 10 HELIX 28 28 ASN A 528 PHE A 533 5 6 SHEET 1 A 2 THR A 3 THR A 5 0 SHEET 2 A 2 THR A 11 THR A 13 -1 O ILE A 12 N ALA A 4 SHEET 1 B11 LEU A 15 ASN A 16 0 SHEET 2 B11 GLU A 21 PRO A 27 -1 O ALA A 22 N LEU A 15 SHEET 3 B11 THR A 99 ARG A 104 -1 O ILE A 100 N ILE A 26 SHEET 4 B11 ILE A 150 VAL A 154 -1 O HIS A 151 N VAL A 103 SHEET 5 B11 LEU A 114 ILE A 120 1 N TRP A 119 O VAL A 152 SHEET 6 B11 GLY A 198 GLU A 208 1 O LYS A 202 N VAL A 116 SHEET 7 B11 ALA A 236 GLN A 240 1 O ALA A 236 N ILE A 205 SHEET 8 B11 VAL A 333 GLN A 338 1 O ILE A 334 N MET A 239 SHEET 9 B11 LYS A 431 SER A 436 1 O SER A 436 N ASP A 337 SHEET 10 B11 LEU A 502 ILE A 505 1 O MET A 503 N SER A 433 SHEET 11 B11 LEU A 510 GLY A 513 -1 O TYR A 511 N MET A 504 SHEET 1 C 2 THR A 227 TYR A 228 0 SHEET 2 C 2 LYS A 231 PRO A 232 -1 O LYS A 231 N TYR A 228 SSBOND 1 CYS A 60 CYS A 97 1555 1555 2.03 SSBOND 2 CYS A 268 CYS A 277 1555 1555 2.03 LINK OG SER A 209 P1 IAN A 560 1555 1555 1.65 LINK ND2 ASN A 314 C1 NAG A 991 1555 1555 1.46 LINK ND2 ASN A 351 C1 NAG B 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.40 LINK OD1 ASP A 260 CA CA A 589 1555 1555 2.77 LINK OD2 ASP A 260 CA CA A 589 1555 1555 2.91 LINK O GLY A 326 CA CA A 590 1555 1555 2.72 LINK O HOH A 538 CA CA A 590 1555 1555 2.81 LINK CA CA A 589 O HOH A 682 1555 1555 2.86 CISPEP 1 SER A 389 PRO A 390 0 0.02 CRYST1 65.000 97.500 176.100 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015385 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010256 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005679 0.00000